Monday, January 27, 2014

A Gene Mutation Linked to Respiratory Infection and Airway Damage

Respiratory infections are known to be the most common illness experienced by individuals worldwide.  It has been shown that repeated respiratory infections can lead to a condition known as “bronchiectasis” that results from a dilation of the bronchi – specialized tubes that carry air from the trachea to the lungs.  Susceptibility to repeated respiratory infections and the resulting bronchiectasis may be due to an underlying primary immunodeficiency (PID).

There have been over 200 genes implicated in PIDs.  This expanded understanding of the role of genetic mutations in regards to susceptibility to respiratory infections among the world’s human population, is due in large part to the application of the advances made in genetic engineering and the fact that the human genome has been entirely deciphered.

To further elucidate the molecular biology of PID, Dr. Ivan Angulo and his colleagues in the Department of Medicine at the University of Cambridge, Cambridge UK, searched for the presence of genetic mutation(s) that might account for PIDs in thirty-five patients suffering from this syndrome.  These patients all suffered from repeated respiratory infections and a family history of susceptibility to these infections.   The fact that a family history was demonstrated, reinforced the assumption of a genetic predisposition.

In regards to the patients studied, the investigators were able to implicate a mutation in the PIK3CD gene that is responsible for the production of the catalytic subunit for the phosphoinositide 3-kinase δ enzyme.  The PID associated with this particular mutation is referred to as the activated PI3K- δ syndrome (APDS).  

An obvious question follows from these results as to the nature of the relationship between the phosphoinositide 3-kinase δ enzyme and the resulting disease state.  The investigators were able to show that the patient-derived immune-competent lymphocytes responsible for combating infection were prone to premature cell death, thereby increasing the likelihood of respiratory distress.  The application of these findings could eventually lead to therapeutic approaches to combat APDS.  

Saturday, January 4, 2014

Hepatitis C Virus – the Core Structure of a Key Viral Protein

Hepatitis C virus (HCV) is a major cause of liver diseases such as hepatitis, cirrhosis of the liver and liver cancer.  This virus was discovered in 1989 and was identified as the causative agent of non-A, non-B hepatitis.  It has now been estimated that 2-3% of the entire world population – an estimated 170 million individuals - is infected with this viral agent.  This reality represents an extraordinary incidence of infection on a global scale.  Therefore, there is much interest in developing an effective vaccine.  This has proved problematic on account of the high variability of the genetic structure of this pathogen analogous to the difficulty in developing an effective vaccine against the human immunodeficiency virus 1 (HIV-1).

A virus, as a class of disease-producing organisms, is essentially dormant until it gains access to its cellular target.  Once it does so, it can subvert the cellular machinery of its host to produce proteins whose structure is dictated by the information found within the virus’ genetic material.  The end result of this process allows the virus to effectively make many copies of itself and eventually kill the host cell and spread the infection. 
Some of the problematic issues that face researchers are the fact that the virus has, as of yet, remained resistant to efforts to grow it in culture and that there is no suitable animal model for the disease.  HCV is a member of the hepacivirus genus.  HV is a so-called retrovirus – analogous to the HIV/AIDS virus.  Its infectious genetic material is RNA.  One of its disturbing features is its ability to produce chronic infection.  An unfortunate side effect of this capability is that of HCV infection can lead to liver cancer – hepatocellular carcinoma.  The development of a reliable vaccine is dependent on a fuller understanding of the particular mode of action of this virus.

In an effort to understand the mechanism of infection of HCV, Dr. Leopold Kong and his associates at the Department of Integrative Structural and Computational Biology at the Scripps Research Institute in La Jolla, California, have examined the molecular mechanism through which HCV gains entry into the target hepatic (liver) cell.  What they have discovered is of particular interest in regards to the eventual production of an effective vaccine.

It seems that at the surface of the virus there is a key glycoprotein (E2) that V H
combines with another glycoprotein, E1, on its surface – a glycoprotein is a kind of protein that is bonded to a sugar.  It is this E1/E2 complex that allows the virus to gain entry into the target cell by preferentially binding to a receptor protein on the cell membrane of liver cells – this receptor is referred to as CD81.  Interestingly, E2 is a target for the body’s natural immune response; however, due to the great variability in the structure of E2, this strategy is essentially ineffective.
 
These investigators were able to determine the three dimensional structure of E2 with a resolution of 2.65 angstroms using X-ray crystallography – an angstrom  is equivalent to one ten-billionth of a meter.  This level of detail may prove to be invaluable in future drug and vaccine design.

Tuesday, December 10, 2013

How Staphylococcus Aureus Evades and Undermines the Immune Response

Staphylococcus aureus is a bacterial pathogen that is largely responsible for human infections that impact the skin and soft tissue.   These kinds of infections can be serious enough to lead to life threatening conditions such as sepsis (blood poisoning as a result of microorganisms or the toxins they produce), endocarditis (inflammation of the interior lining of the chambers of the heart) and bacteremia (bacteria in the blood).  A distinctive characteristic of a staphylococcal infection is the formation of abscesses that are comprised of bacterial colonies surrounded by fibrin – a structural protein.  The severity of infections with this organism has been attributed to its ability to evade and undermine the immune response.   It is, therefore, essential to understand the nature of its mechanism of action in regard to defending itself from the immune system.

Human immunity can be delineated into two distinct responses.  The first if referred to as the “innate” response and the second as the “adaptive” response.  The former is designed to respond immediately to an invasion by deleterious organisms such as bacteria.   The adaptive response is typically secondary and engages the T and B lymphocyte populations that are in constant circulation within the blood and lymph systems.  This response affords more enduring and long term immunity to the insulting microorganism(s).
As part of the innate response to Staphylococcus aureus infection, neutrophils – white blood cells that move to the site of infection – release their DNA in the a form that is referred to as neutrophil extracellular traps (NETs).   The intrinsic purpose of these NETs is to immobilize the pathogen and enhance the activity of peptides – small proteins – that possess anti-bacterial activity.  However, Staphylococcus aureus effectively undermines this immune response.

The mechanism of action that the pathogen employs to counteract the role of neutrophils has been characterized through the efforts of Dr. Vilasack Thammavongsa and his colleagues at the Department of Microbiology of the University of Chicago.   As a result of their research efforts, they discovered that staphylococcus aureus sidesteps the innate immune response by effectively converting NETs to deoxyadenosine.   This modification is a product of two enzymes – nuclease and adenosine synthase – secreted by the pathogen.  This action triggers the destruction of immune cells and also prevents macrophages – white cells whose role is to ingest invading organisms - from entering the staphylococcal abscesses.


This finding is of great value; for, it helps elucidates the mechanism through which staphylococcus successfully evades the human immune system.

Tuesday, November 19, 2013

A Comparison of the Deleterious Impact of Human Exposure to Methylmercury and PCBs

In a scientific paper entitled, Neurobehavioral toxicity of methylmercury and PCBs Effects-profiles and sensitive populations authored by Dr. Christopher Newland from the Department of Psychology, Auburn University that appeared in the Journal of Environmental Toxicology and Pharmacology, the investigator compares the toxicology of methylmercury and polychlorinated biphenyls (PCBs) in human populations.
Both methylmercury and PCBs are known to be potent neurotoxic agents that have deleterious consequences in terms of the sensory, motor and cognitive abilities of those who have suffered sufficient exposure.

PCBs represent a class of compounds in which over 200 separate substances are members.  There appears to be a wide range of varying toxic effects among these substances depending upon their precise molecular structure.  However, they all bind to the aryl hydrocarbon receptor (ahr) found on the surface of mammalian cells.  Disruption of the usual binding to the Ah receptor can play havoc with the healthy functioning of the nervous system and can account for the wide-ranging toxic effects of PCBs.

Methylmercury is the toxic form of mercury that human populations are usually exposed to.  When ingested it is rapidly absorbed by the gut into the bloodstream and can penetrate the blood-brain barrier by two routes.  It can passively pass through this barrier due to its lipid solubility.  Secondarily, it can actively combine with the amino acid cystein that is one of the 20 amino acids that are the building blocks for the synthesis of proteins.  Once bound it readily penetrates the blood-brain barrier carried by a methionine transporter. The blood-brain barrier is the physiological barrier that usually protects the brain from any foreign and potentially harmful substances that may be circulating in the bloodstream.  Once within the brain the methyl group is enzymatically removed leaving the highly toxic mercury that can persist for a prolonged period of time.
  
According to the author, “methylmercury exposure affects the visual, auditory, and somatosensory systems.”
In addition, “Methylmercury exposure during adulthood produces a progressive and irreversible constriction of the visual field a pattern of toxicity not associated with developmental exposures. Methylmercury exposure during gestation or lactation affects higher-order visual function.”  Motor damage including nystagmus – rapid involuntary movement of the eyes -  that suggests damage to the cerebellum and cerebral palsy that suggests damage to the cerebral cortex have been shown in victims of the Minamata exposure in Japan as previously described.

Since PCBs and methylmercury contaminants are both found in fish and since seafood is the usual route of exposure of these dangerous chemicals for humans, it would be efficacious, from a public health standpoint, to examine the synergistic effects of these compounds on human health.   

Wednesday, November 13, 2013

The Legacy of Mercury Poisoning in Japan

It has been almost sixty years since medical investigators first pinpointed the nature of an apparently new illness that struck the residents of Minamata, Japan.  This disease came to be referred to as Minamata Disease.   It all seemed to have begun during the spring and summer of 1956 with the appearance of what was referred to at the time as a strange disease that impacted fishing families living in villages in and around Minamata Bay. 

The symptoms that the victims of this ailment presented were numb hands and feet, sudden difficulty in walking and a definitive impairment in speech.  Extreme cases resulted in convulsions and death.  Of the 54 cases that presented with this disease in 1956, 31% died.   This was a disturbing statistic.  This galaxy of symptoms suggested a neurological basis for the disease.

By the year’s end researches at Kumamoto University had identified the etiology of the illness as being heavy metal poisoning from the ingestion of contaminated local fish and shellfish.   This diagnosis was consistent with the evidence; heavy metals are known to play havoc with the nervous system as exemplified by lead poisoning.  It remained to discover the origin of the contamination and the offending metal.
  
Investigators focused on the Shin Nippon Chisso Hiryo chemical plant facility that had been known to discharge its untreated waste directed into the local waterways.   The plant owners managed to delay a thorough investigation for a number of years.  Ultimately the chemical culprit was discovered – methyl mercury, a highly toxic substance.

It was not until May of 1968 that the plant halted production of acetaldehyde that employed a mercury catalyst in its chemical synthesis.  This overdue decision finally halted its use of mercury.  Furthermore, even though it was shown that there existed a persistent contamination of  methylmercury  on the seafloor,  Minamata Bay was not closed for fishing until 1975.


To this day, the research continues regarding the long term effects of the ingestion of low levels of methyl mercury from contaminated seafood.  The controversy has not subsided regarding who has been victimized and who is liable for the costly toll on individual lives.

Friday, November 1, 2013

Viral-and Bacterial Co-infection

An unfortunate side effect of infection with the flu virus is a secondary bacterial pneumonia often called a co-infection.  This complication can prove to be very deleterious especially among at-risk populations such as the elderly.  The actual cause of this apparent increased susceptibility has not been well defined.
There are two disparate routes through which the immune system can exert its effect.  The more readily understood strategy is referred to as resistance in which the immune system is mobilized to detect the offending pathogen and eliminate it.  There is, however, another route that the immune system can take and that is tolerance in which the immune system adapts to a certain level of tissue damage inflicted by the offending organism.  Interestingly enough, the deleterious impact of infectious disease can be the result of either failed resistance or failed tolerance.

Usually, a deadly outcome of a microbial infection is relegated to either high virulence or decidedly poor resistance on the part of the host immune system.  However, there is another possible explanation.   The damage produced by an invading pathogen can be directly related to the toxins it produces, or to the inflammatory response precipitated by the immune system that can lead to tissue damage.  This latter effect is referred to as “extrinsic virulence.”  Insufficient tissue protection and subsequent repair of damaged tissue can also contribute to the lethality of the infectious process.
   
Dr. Amanda Jamieson and her colleagues at the Howard Hughes Medical Institute and Department of Immunobiology at the Yale University School of Medicine chose to study the co-infection of the influenza virus with Legionella pneumophila using a mouse model as a way of determining whether it is resistance or tolerance on the part of the host immune system that determines lethality.

Through their detailed studies, they found that susceptibility to co-infection occurred even when the bacterial infection was controlled by the immune system.  From this, they were able to conclude that the failure of host defenses was directly related to a diminished capacity to tolerate tissue damage.
 

This is a very interesting finding that may have practical implications regarding the clinical approach to patients whose health is seriously impacted by co-infection.

Tuesday, October 8, 2013

Behavioral Disturbances as a Result of Inner Ear Defects

Inner ear defects in children can lead to a severe hearing loss.  A subset (20 – 95%) of these children also experience vestibular dysfunction pertaining to balance.  This latter condition is related to the fact that within the inner ear resides an anatomical structure referred to as the cochlea.  The cochlea serves both auditory and balance functions.

Interestingly enough, among these cases, there also exists a high incidence of behavioral issues including hyperactivity.  It has been proposed that socio-environmental factors could be risk factors that would help explain this relationship.  Another possibility is that the associated inner ear defect might directly modify brain structure and thereby result in behavioral dysfunction.

To test this hypothesis, Dr. Michelle W. Antoine and her colleagues - from the Department of Neuroscience at the Albert Einstein College of Medicine, Bronx, New York - using the mouse animal model and applying the tools available in Molecular Biology have uncovered a link between inner ear defects and discreet molecular changes within the brain.

In the genetic mouse model that was studied, the same correlation exists between inner ear defect and increased levels of hyperactivity as was found in humans.  It seems that a gene referred to as Slc12a2 is responsible for a protein product that functions as a sodium-potassium-chloride co-transporter that is expressed in many tissues including the inner ear and the central nervous system (CNS).  It is precisely this gene that is mutated in the mouse model studied.  This mutated gene is rendered non-functional.  It is therefore quite plausible that the loss of this gene could result in both inner ear defect and the behavioral disorder characterized by hyperactivity.

In attempt to further elucidate the mechanism by which motor activity is heightened in the effected mice, the investigators found that within the nucleus accumbens – an area of the mammalian brain that plays a role in fear, aggression of impulsivity – the levels of key mediators of neuronal activity were increased.  These mediators include pCREB and pERK.  In addition, hyperactivity was alleviated upon the administration of the pERK inhibitor, SL327.


These findings are of great importance; for they demonstrate that, “sensory impairment, such as inner ear dysfunction, can induce specific molecular changes in the brain that cause maladaptive behaviors, such as hyperactivity, that have been traditionally considered exclusively of cerebral origin.”